Results 41 to 50 of about 3,178,330 (288)

SASOP Biological Psychiatry Congress 2013 Abstracts

South African Journal of Psychiatry, 2013
List of abstracts and authors: 1. Bipolar disorder not otherwise specified -overdiagnosed or underdiagnosed? E Allers 2. The prognosis of major depression untreated and treated: Does the data reflect the true picture of the prognosis of this very ...
E Allers, E Allers, O A Betancourt, J Benson-Martin, P Buckley, P Buckley, I Chetty, B Chiliza, P Cilliers, H Clark, P Cowen, L Dannatt, A K Domingo, K Domschke, S du Plessis, P Haddad, S Hemmings, D C Henderson, V Hitzeroth, B Janse van Rensburg, S Janse van Rensburg, G Jordaan, L Kramer, A Lachman, B Latecki, P Macqueen, N McGregor, A Moodley, Z M Moosa, L Mubaiwa, M Nagdee, C Nemeroff, G Nortje, A Ojagbemi, E Peter, L Phahladira, W Pienaar, S Ramlall, S Rataemane, A Roos, D Rosenstein, J Roux, C Schumann, M Solms, G Spies, U Subramaney, S Suliman, S Suomi, C Szabo, H Uys, J van Tonder, J Zohar, S Bakelaar, E Breet, A Bronkhorst, W Davis, D de Klerk, D Delport, B Drögemöller, E du Toit, J P Fouche   +60 more
doaj   +1 more source

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism

, 2008
These practice guidelines for the biological treatment of substance use disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal during the development of these guidelines was
Johnson, BA, Kranzler, HR, Hesselbrock, V, the WFSBP Task Force on Treatment Guidelines for Substance Use Disorders, .reatment Guidelines for Substance Use Disorders, Soyka, M, Gorelick, D, Moller, H-J, Berglund, Mats,, Henry R. Kranzler, David Gorelick, Michael Soyka, Mats Berglund, Victor Hesselbrock, THE WFSBP TASK FORCE ON TREATMENT G, Hans-Jürgen Möller, Bankole A. Johnson   +15 more
core   +1 more source

Translational significance of neurodevelopment underpinned ‘neurophysiological-cognitive’ biomarkers in schizophrenia

Indian Journal of Psychiatry
Biomarker research helps validate diagnostic entities that are otherwise based on pure clinical sense and prone to subjectivity bias. Biomarker research in the field of schizophrenia and psychoses dates back to more than a century. However, the focus on ‘
Sai Krishna Tikka
doaj   +1 more source

The Quest for Psychiatric Advancement through Theory, beyond Serendipity

Brain Sciences, 2021
Over the past century, advancements in psychiatric treatments have freed countless individuals from the burden of life-long, incapacitating mental illness. These treatments have largely been discovered by chance.
Robert E. Kelly, Anthony O. Ahmed, Matthew J. Hoptman, Anika F. Alix, George S. Alexopoulos   +4 more
doaj   +1 more source

Meynert and the biological German psychiatry

Arquivos de Neuro-Psiquiatria, 2012
Theodor Hermann Meynert (1833-1892), a German-Austrian neuropathologist and anatomist, is known as one of the founders of the Brain Psychiatry. He was the most arduous defender of the bridge between psychological and neurophysiological events, both ...
Marleide da Mota Gomes, Eliasz Engelhardt   +1 more
doaj   +1 more source

The computational psychiatry of reward: Broken brains or misguided minds?

Frontiers in Psychology, 2015
Research into the biological basis of emotional and motivational disorders is in danger of riding roughshod over a patient-centred psychiatry and falling into the dualist errors of the past, i.e. by treating mind and brain as conceptually distinct.
Michael eMoutoussis, Giles eStory, Ray eDolan, Ray eDolan   +3 more
doaj   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub, Michele K. York, Roseanne Dobkin, Anuprita R. Nair, Ryan Kurth, David‐Erick Lafontant, Chelsea Caspell‐Garcia, Roy N. Alcalay, Ethan G. Brown, Lana M. Chahine, Christopher Coffey, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kenneth Marek, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, Andrew Siderowf, Cristina Simonet, Tanya Simuni, Caroline M. Tanner, Thomas F. Tropea, Aleksandar Videnovic, The Parkinson's Progression Markers Initiative   +24 more
wiley   +1 more source

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni, Cecile Pagan, Antony Citterio‐Quentin, Isabelle Rouvet, Giulia Dingeo, Cyril Hanin, Claudine Laurent‐Levinson, Samia Pichard, Bénédicte Héron, Clément Gourguechon, Daniele Mandia, Jerome Guitton, Carole Lacout, Nicolas Schleinitz, Florient Potier, Olivier Flabeau, Elsa Besse‐Pinot, Foudil Lamari, Magali Pettazzoni, Yann Nadjar   +19 more
wiley   +1 more source

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

, 2013
These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia published in 2006.
Alkomiet Hasan, Birte Glenthoj, von Knorring, Lars,, Hasan, Alkomiet, Thibaut, Florence, Falkai, Peter, Wagner F. Gattaz, Wobrock, Thomas, Möller, Hans-Jürgen, Florence Thibaut, Thomas Wobrock, Lieberman, Jeffrey, Jeffrey Lieberman, Gattaz, Wagner F, Peter Falkai, Glenthoj, Birte, Hans-Jürgen Möller   +16 more
core   +1 more source